VanEck Pharmaceutical ETF (NASDAQ:PPH) Plans Quarterly Dividend of $0.62

VanEck Pharmaceutical ETF (NASDAQ:PPHGet Free Report) declared a quarterly dividend on Tuesday, June 30th, NASDAQ Dividends reports. Investors of record on Wednesday, July 1st will be given a dividend of 0.6248 per share on Tuesday, July 7th. This represents a c) dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Wednesday, July 1st.

VanEck Pharmaceutical ETF Stock Down 1.3%

VanEck Pharmaceutical ETF stock traded down $1.40 during midday trading on Wednesday, hitting $107.95. The company’s stock had a trading volume of 219,351 shares, compared to its average volume of 334,346. The stock’s 50-day moving average price is $103.49 and its 200-day moving average price is $104.82. VanEck Pharmaceutical ETF has a 12 month low of $81.74 and a 12 month high of $112.58. The company has a market capitalization of $1.02 billion, a PE ratio of 20.21 and a beta of 0.47.

VanEck Pharmaceutical ETF Company Profile

(Get Free Report)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.

See Also

Dividend History for VanEck Pharmaceutical ETF (NASDAQ:PPH)

Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.